Summary & Overview
HCPCS J3265: Injection, Torsemide 10 mg/ml
HCPCS Level II code J3265 identifies the injectable formulation of torsemide at 10 mg/ml. Torsemide is an intravenous or intramuscular loop diuretic used to manage fluid overload and edema in acute and chronic conditions. Use of a specific HCPCS J‑code enables standardized billing for the drug component of injectable administration and supports payer adjudication across facility and professional settings.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of how J3265 is classified, its clinical role in diuretic therapy, and the typical sites of service where injectable torsemide is administered. The publication also summarizes common billing considerations, typical modifiers encountered in claims, and related service-line implications.
This summary provides clinical context and billing orientation for health system coders, revenue cycle teams, and policy analysts seeking a concise reference for J3265. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J3265 describes injection, torsemide, 10 mg/ml. This code represents a parenteral loop diuretic formulation used for intravenous or intramuscular administration when torsemide is required for management of fluid overload, edema, or related clinical indications.
Service type: Medication administration via injection.
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, physician office, or other outpatient infusion/administration settings where injectable diuretics are provided.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic volume overload from congestive heart failure or acute decompensated heart failure who requires intravenous loop diuretic therapy because oral diuretics are ineffective or absorption is unreliable. The patient arrives to an outpatient infusion center, emergency department, or hospital inpatient ward for administration of J3265 (injection, torsemide, 10 mg/ml). Clinical workflow: triage and nursing assessment (vital signs, weights, intake/output), review of current medications and renal function, baseline electrolyte and creatinine laboratory tests, physician or advanced practice clinician orders the J3265 dose and administration route (typically IV bolus or slow IV push), nursing prepares and administers the torsemide, monitors for response (urine output, symptom relief) and adverse effects (hypotension, hypokalemia, renal impairment), and documents dose, lot number, time, and any modifiers relevant to payer billing. Typical sites of service include outpatient infusion centers, hospital inpatient units, emergency departments, and physician offices with parenteral administration capability. Patient scenario example: a 68-year-old with chronic heart failure with reduced ejection fraction presenting with 3 days of increasing dyspnea and peripheral edema, inadequate response to oral diuretics, receiving IV J3265 torsemide with close monitoring of urine output and serum electrolytes.
Coding Specifications
| Modifier | Description | When to Use |
|---|